大连市西岗区2005～2016年恶性肿瘤登记数据质量评价

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (0 KB) HTML (42 KB)
Export: BibTeX | EndNote (RIS)

Abstract

Objective To evaluate the data of the malignant tumor registration report from January 2005 to December 2016 in Xigang District of Dalian City in the aspects of data reliability and registration completeness, so as to provide a basis for further improving the quality of tumor registration.Methods All morbidity and mortality cases diagnosed as malignant tumors in Xigang District of Dalian City from January 2005 to December 2016 were exported from Dalian Cancer Registration Report Management System.Through SAS programming, the data were merged, deduplicated, summarized and analyzed, and statistical charts were generated.Results The proportion of histopathology (MV%) in Xigang District from January 2005 to December 2016 was 72.88%, cases with death certificate notification (DCN) accounted for 18.78%, and cases with death certificate only (DCO) accounted for 2.85%.There was still a certain gap from the national standard of <15%.The ratio of the number of deaths to the number of new cases (M/I) was 0.41, which did not reach the standard of 0.6-0.8.The percentage of new cases of malignant tumors registered in the same period, with other unspecified sites and unknown primary sites (secondary) (O&U%) was 3.13.Conclusion The MV% in Xigang District from January 2005 to December 2016 is higher than the national standard.However, the number of DCN cases has been in an increasing trend in recent years, reaching 35.54% in 2016.M/I is 0.41, less than the standard of 0.6-0.8, which is related to the high incidence rate of thyroid cancer, breast cancer and other tumors with good prognosis in Dalian City.The O&U% is 3.13%, but increases to 4.24% in 2016.In recent years, it has been gradually increasing, but the overall level is not high.In general,the reliability of tumor registration data in Xigang District of Dalian City is relatively high, but the completeness is not high, so it needs to be strengthened urgently.

Key words： Tumor registration Cases of malignant tumor Morbidity Mortality

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I20/183

[1]	张莉梅，林红，郭昀.大连市肿瘤登记报告工作回顾与现状[J].中国肿瘤，2007，16（1）：17-19.
[2]	王世平，于萍，张莉梅.大连市肿瘤管理信息系统的建设[J].中国肿瘤，2012，21（2）：96-97.
[3]	张莉梅.大连市肿瘤登记模式完善与网络信息系统建设[J].中国肿瘤，2009，18（5）：356-357.
[4]	张思维.肿瘤登记软件CanReg4 简介[J].中国肿瘤，2002，11（5）：261-262.
[5]	杨国庆.医院为基础肿瘤登记流程分析与设计[D].太原：山西医科大学公共卫生学院，2012.
[6]	陈万青，夏庆民.进一步推进中国肿瘤登记工作[J].中国肿瘤，2013，22（1）：1.
[7]	陈万青，梁智恒，岑惠珊，等.中国肿瘤登记现况及发展[J].中国医学前沿杂志（电子版），2016，8（7）：1-6.
[8]	张思维，陈万青，王乐.中国肿瘤登记工作30年[J].中国肿瘤，2009，18（4）：256-259.
[9]	彭慧，黄芳，张一英，等.上海市嘉定区2002～2012年恶性肿瘤登记资料质量评价[J].中国肿瘤，2016，25（10）：775-781.
[10]	庹吉妤，张敏，常江，等.2012年湖北省肿瘤登记地区恶性肿瘤发病与死亡情况分析[J].肿瘤防治研究，2016，43（11）：974-979.
[11]	王孟，李变云，马山蕊，等.2011年林州市肿瘤登记资料质量控制数据分析[J].河南预防医学杂志，2016，27（3）：161-166.
[12]	王新正，元芳梅，张永贞.阳城县肿瘤登记资料质量评价[J].中国肿瘤，2012，21（1）：39-41.
[13]	王悠清，杜灵彬，李辉章，等.浙江省肿瘤登记地区2012年恶性肿瘤发病与死亡分析[J].中国肿瘤，2016，25（1）：9-19.
[14]	张婷，胡文斌，邵勇，等.2012年江苏省昆山市肿瘤登记质量评价和发病分析[J].现代预防医学，2016，43（3）：470-474.
[15]	周海滨，池洪珊，彭绩.深圳市肿瘤登记工作评价与分析[J].中国肿瘤，2010，19（7）：427-429.
[16]	Curado MP，Voti L，Sortino-Rachou AM.Cancer registration data and quality indicators in low and middle income countries：their interpretation and potential use for the improvement of cancer care[J].Cancer Causes Control，2009，20（5）：751-756.
[17]	Gammelager H，Christiansen CF，Johansen MB，et al.Quality of urological cancer diagnoses in the Danish National Registry of Patients[J].Eur J Cancer Prev，2012，21（6）：545-551.
[18]	Moore MA.Overview of cancer registration research in the Asian Pacific from 2008-2013[J].Asian Pac J Cancer Prev，2013，14（8）：4461-4484.
[19]	Pearce N，Blair A，Vineis P，et al.IARC monographs：40 years of evaluating carcinogenic hazards to humans[J].Environ Health Perspect，2015，123（6）：507-514.
[20]	Rashbass J，Peake M.The evolution of cancer registration[J].Eur J Cancer Care （Engl），2014，23（6）：757-759.
[21]	Crocker-Buque T，Pollock AM.Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008：a review of the literature and critical appraisal[J].J R Soc Med，2015，108（2）：57-67.
[22]	Dehler S，Tonev S，Korol D，et al.Recent trends in cancer incidence：impact of risk factors，diagnostic activities and data quality of registration[J].Tumori，2014，100（4）：399-405.
[23]	Wei KR，Chen WQ，Zhang SW，et al.Cancer registration in the Peoples Republic of China[J].Asian Pac J Cancer Prev，2012，13（8）：4209-4214.
[24]	廖媚君.病案管理中出现肿瘤编码错误的原因分析[J].汕头大学医学院学报，1997，10（4）：76-78.
[25]	马新源，姚开颜.提高肿瘤登记资料质量的几点体会[J].中国肿瘤，2003，12（3）：13-14.